 | • レポートコード：MRC2303K029 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：食品 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の調査レポートでは、世界の眼用健康サプリメント市場規模が、予測期間中（2022年-2027年）、CAGR 6.5％で増大すると予測されています。本レポートでは、眼用健康サプリメントの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（酸化防止剤、脂肪酸、抗炎症サプリメント、神経保護サプリメント、その他）分析、疾患別（加齢黄斑変性（AMD）、白内障、ドライアイ症候群、糖尿病性網膜症、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などについて調査・分析などの項目を掲載しています。並び、こちらのレポートには、Bausch & Lomb Incorporated、Pfizer, Inc.、Amway International、Akorn Consumer Health、Vitabiotics Ltd、ZeaVision, LLC、Nature's Bounty Co.、Nutrivein、Kemin Industries, Inc.、EyeScience Labs、Zenith Labs、Performance Lab Ltd.、Nuzena LLCなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の眼用健康サプリメント市場規模：種類別 - 酸化防止剤の市場規模 - 脂肪酸の市場規模 - 抗炎症サプリメントの市場規模 - 神経保護サプリメントの市場規模 - その他眼用健康サプリメントの市場規模 ・世界の眼用健康サプリメント市場規模：疾患別 - 加齢黄斑変性（AMD）における市場規模 - 白内障における市場規模 - ドライアイ症候群における市場規模 - 糖尿病性網膜症における市場規模 - その他疾患における市場規模 ・世界の眼用健康サプリメント市場規模：地域別 - 北米の眼用健康サプリメント市場規模 アメリカの眼用健康サプリメント市場規模 カナダの眼用健康サプリメント市場規模 メキシコの眼用健康サプリメント市場規模 … - ヨーロッパの眼用健康サプリメント市場規模 ドイツの眼用健康サプリメント市場規模 イギリスの眼用健康サプリメント市場規模 フランスの眼用健康サプリメント市場規模 … - アジア太平洋の眼用健康サプリメント市場規模 中国の眼用健康サプリメント市場規模 日本の眼用健康サプリメント市場規模 インドの眼用健康サプリメント市場規模 … - 南米/中東の眼用健康サプリメント市場規模 南アフリカの眼用健康サプリメント市場規模 ブラジルの眼用健康サプリメント市場規模 アルゼンチンの眼用健康サプリメント市場規模 … ・競争状況 ・市場機会・将来動向 |
The eye health supplement market is projected to register a CAGR of 6.5% during the forecast period (2022-2027).
Many countries around the world have imposed nationwide lockdowns since the World Health Organization declared Coronavirus Disease 2019 (or COVID-19) to be a pandemic on March 11, 2020. Routine healthcare services were canceled, and patients were advised to avoid hospital visits unless critically necessary, to minimize the risk of COVID-19 transmission. These trends led to significant disruption to the provision of eye healthcare services and patient care. As per the study published in October 2020, titled “The impact of COVID-19 pandemic on ophthalmology services: are we ready for the aftermath?”, ophthalmology represented one of the busiest and most heavily outpatient-oriented specialties, with approximately 7.5 million outpatient appointments and more than 500,000 surgical procedures in the United Kingdom each year. The recent pandemic lockdown resulted in the cancellation of thousands of ophthalmic clinical visits and surgeries, which could potentially lead to permanent and significant harm to patients’ vision. The study also reported a significant impact of the COVID-19 pandemic on the ophthalmology service in India, with clinical and surgical services being reduced by >95%. Such a decrease in patient visits impacted the adoption of eye health supplements among the patient population. However, owing to teleconsultations and virtual care practices, the demand for eye health supplements is likely to soar to its pre-pandemic levels in the near future. Thus, in view of its elective nature, the cancellation of routine ophthalmic visits in the initial pandemic phase had an adverse impact on the market’s growth. However, the market is anticipated to gain traction over the coming years.
The major drivers propelling the growth of the eye health supplement market are the increasing prevalence of eye disorders globally. The studied market is expected to be driven by the growing global geriatric population and diabetes, as uncontrolled diabetes leads to diabetic retinopathy. According to the United Nations, World Population Ageing 2019, there were 703 million people aged 65 years or over in the world in 2019, and the number is projected to double to 1.5 billion in 2050. As per the World Health Organization Statistics of 2021, globally, at least 2.2 billion people have a near-or distance vision impairment. In at least 1 billion, or almost half of these cases, vision impairment could have been prevented or has yet to be addressed. Furthermore, as per the Dry Eye Directory’s statistics for 2022, between 16 million and 49 million Americans currently have dry eyes. This is between 5-15% of the population. The increasing prevalence of eye disorders is likely to impel the demand for eye health supplements among the patient population.
Besides, the launch of innovative products is also boosting the market’s growth. For instance, in July 2021, Healthy Directions announced the introduction of Vision Essentials ULTRA, a breakthrough one-a-day vision supplement in its highly popular and efficacious Whitaker Nutrition line. Likewise, in May 2021, PharmaLinea launched a line of preventative eye health supplements in consumer-friendly formats. The decision came as a result of the pandemic, which has increased screen time and contributed to an increase in eye health concerns. Also, in February 2021, Unibar Corporation announced a partnership with Health Thru Nutrition and the availability of the Health Thru Nutrition Capsanthin supplement containing CapsiClear.
Thus, owing to the aforementioned factors, the studied market is expected to propel over the forecast period. However, higher costs associated with eye health supplement products are likely to impede market growth.
Eye Health Supplement Market Trends
Antioxidant Segment is Expected to Show Better Growth over the Forecast Period
The rise in the geriatric population, the increasing prevalence of diabetes, and eye disorders such as age-related macular degeneration (AMD), cataract, diabetic retinopathy, and other eye disorders are expected to drive the growth of the studied market in North America. Besides, macular degeneration, often called age-related macular degeneration (AMD), is an eye disorder associated with aging and results in damaged sharp and central vision. As per the Macular Degeneration Research 2021, macular degeneration is a leading cause of vision loss in Americans aged 60 years of age and older. As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. Age is a prominent risk factor for age-related macular degeneration. The risk of getting advanced age-related macular degeneration increases from 2% for those ages 50–59 to nearly 30% for those over the age of 75.
Additionally, the increasing concentration of major players and new product launches in the region adds to the growth of the studied market. For instance, in July 2019, Bausch + Lomb launched Ocuvite Eye Performance, an eye vitamin supplement formulated with seven vital nutrients that help strengthen the macula and protect the eye from stress in the United States. Likewise, the major players are evolving various strategies, such as investment in research and development, collaborations, and acquisitions, for the expansion of their product portfolios in the region. One such collaboration was the partnership agreement of ZeaVision LLC. (EyePromise) with the Boston Red Sox in November 2019 as an official eye vitamin brand throughout 2020.
In December 2021, TJ Nutrition, a Texas nutraceutical company that creates one-of-a-kind, patented supplements based on genetic disease investigators’ clinical research, announced the launch of Parasym Plus Eyes, a revolutionary and patented compound scientifically proven to increase tear production while reducing inflammation. By enhancing both lacrimal and vagus nerve function, Parasym Plus Eyes improves both systemic and ocular health neurologically and concurrently.
Thus, in view of the aforementioned factors, North America is expected to contribute significantly to the eye health supplement market over the forecast period.
North America has a Dominant Share in Eye Health Supplements Market and is Anticipated to Grow Tremendously over the Forecast Period
The rise in the geriatric population, the increasing prevalence of diabetes, and eye disorders such as age-related macular degeneration (AMD), cataract, diabetic retinopathy, and other eye disorders are expected to drive the growth of the studied market in North America. Besides, macular degeneration, often called age-related macular degeneration (AMD), is an eye disorder associated with aging and results in damaged sharp and central vision. As per the Macular Degeneration Research 2021, macular degeneration is a leading cause of vision loss in Americans aged 60 years of age and older. As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. Age is a prominent risk factor for age-related macular degeneration. The risk of getting advanced age-related macular degeneration increases from 2% for those ages 50–59 to nearly 30% for those over the age of 75.
Additionally, the increasing concentration of major players and new product launches in the region adds to the growth of the studied market. For instance, in July 2019, Bausch + Lomb launched Ocuvite Eye Performance, an eye vitamin supplement formulated with seven vital nutrients that help strengthen the macula and protect the eye from stress in the United States. Likewise, the major players are evolving various strategies, such as investment in research and development, collaborations, and acquisitions, for the expansion of their product portfolios in the region. One such collaboration was the partnership agreement of ZeaVision LLC. (EyePromise) with the Boston Red Sox in November 2019 as an official eye vitamin brand throughout 2020.
In December 2021, TJ Nutrition, a Texas nutraceutical company that creates one-of-a-kind, patented supplements based on genetic disease investigators’ clinical research, announced the launch of Parasym Plus Eyes, a revolutionary and patented compound scientifically proven to increase tear production while reducing inflammation. By enhancing both lacrimal and vagus nerve function, Parasym Plus Eyes improves both systemic and ocular health neurologically and concurrently.
Thus, in view of the aforementioned factors, North America is expected to contribute significantly to the eye health supplement market over the forecast period.
Eye Health Supplement Market Competitor Analysis
The Eye Health Supplement market is highly competitive and consists of many major players that dominate the market. Also, many small and medium-sized companies are also actively involved in R&D activities and trying to set foot in the studied market, thereby leading to an impactable growth over the forecast period. The major players in the studied market are Bausch & Lomb, Incorporated, ZeaVision, LLC., Amway International, Akorn Consumer Health, Vitabiotics Ltd, and Nature’s Bounty, Co., among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Eye disorders
4.2.2 Growing Geriatric Population and High Incidence of Diabetes
4.2.3 Increased Usage of Screens and Monitors in Daily Routine
4.3 Market Restraints
4.3.1 High Cost of Eye Care Supplements
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Antioxidants
5.1.2 Fatty Acids
5.1.3 Anti-inflammatory Supplements
5.1.4 Neuro-Protective Supplements
5.1.5 Others
5.2 By Indication
5.2.1 Age-Related Macular Degeneration (AMD)
5.2.2 Cataract
5.2.3 Dry Eye Syndrome
5.2.4 Diabetic Retinopathy
5.2.5 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bausch & Lomb Incorporated
6.1.2 Pfizer, Inc.
6.1.3 Amway International
6.1.4 Akorn Consumer Health
6.1.5 Vitabiotics Ltd
6.1.6 ZeaVision, LLC
6.1.7 Nature’s Bounty Co.
6.1.8 Nutrivein
6.1.9 Kemin Industries, Inc.
6.1.10 EyeScience Labs
6.1.11 Zenith Labs
6.1.12 Performance Lab Ltd.
6.1.13 Nuzena LLC
7 MARKET OPPORTUNITIES AND FUTURE TRENDS